<DOC>
	<DOCNO>NCT01748435</DOCNO>
	<brief_summary>Neuropathic ( nerve pain ) follow amputation limb common , affect 60-80 % patient ( Sherman et al , 1984 ) . It prolong recovery make difficult fit protheses mobilise . Current treatment option limit exist painkiller significant side effect . Nevertheless evidence pre-emptive analgesia ( pain relief provide prior surgery ) additional benefit surgery ( Ypsilantis &amp; Tang , 2010 ) Qutenza ( topical capsaicin 8 % ) novel analgesic agent apply directly onto skin . It work desensitise pain receptor skin ( Nolano et al. , 1999 ) show effective reduce neuropathic pain condition ( Backonja et al. , 2008 ) We propose evaluate use Qutenza pre-emptive analgesia patient undergoing amputation limb . This small , pilot , randomise control study 30 patient undergo low limb amputation Qutenza active control apply prior surgery . They follow 12 week post-operatively regular assessment pain score , quality life wound healing .</brief_summary>
	<brief_title>Pre-emptive Analgesia With Qutenza Lower Limb Amputation</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>All adult patient &gt; 18 year old undergoing low limb amputation Traumatic amputation Severe active sepsis nonviable limb Illness necessitate urgent surgery &lt; 24 hour admission hospital Hypersensitivity Qutenza , Emla excipients Broken skin active ulceration site application Severe uncontrolled hypertension ( systolic BP &gt; 200 ) Proven cardiac event precede 3 month Women pregnant breast feed Lack capacity inability provide inform consent Declines participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Lower limb amputation</keyword>
	<keyword>Pre-emptive analgesia</keyword>
</DOC>